← FDA Drug Approvals (Drugs@FDA)
SITAGLIPTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA LTD · Approved 2024-01-02
Drug application
- FDA Application #
ANDA216919- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SITAGLIPTIN
- Generic name
- Sitagliptin Phosphate
- Active ingredients
- SITAGLIPTIN PHOSPHATE
- Dosage form
- TABLET
- Route
- FILM COATED
- Marketing status
- None (Tentative Approval)
- Sponsor
- MANKIND PHARMA LTD
- First approval
- 2024-01-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown